Navigation Links
Clinical Conductor CTMS Partners with the Greater Gift Initiative to Donate Vaccines
Date:10/24/2013

Winston-Salem, NC and Rochester, NT (PRWEB) October 24, 2013

The fall conference schedule for the Clinical Trial Industry is in full swing,and Clinical Conductor CTMS, the leading clinical trial management system for research organizations from Bio-Optronics, is actively participating in many events to talk and meet with clinical trial professionals about its family of clinical trial management systems. This year, Clinical Conductor is sharing booth space with the Greater Gift Initiative (GGI) and donating vaccines in honor of conference participants. “We are so appreciative of Clinical Conductor’s support of GGI and their donation of vaccines in honor of visitors to the booth,” says Becca Chase, Executive Director of GGI. “Talking with conference participants in the exhibit hall is a great opportunity to tell the GGI story and ultimately have more clinical trial sites honor their volunteers with the gift of a vaccine to a child in need.” Clinical Conductor donated vaccines on behalf of every attendee at the 2013 Site Solutions Summit held October 11-13 to recognize the Society for Clinical Research Sites (SCRS) for its commitment to helping clinical research sites reach their true potential. In addition to the donations made at the Site Solutions Summit, Clinical Conductor is donating vaccines in honor of participants who visit its booth at CenterWatch’s fall 2013 Forum on Optimizing Clinical Research Performance this week in Las Vegas, Nevada, and at the upcoming MAGI West Clinical Research Conference in Las Vegas on October 27-30. The vaccine donations are being made through the Greater Gift Initiative, whose mission is to advance global health and highlight the greater good of clinical trial participation by gifting a vaccine to a child in honor of every clinical trial volunteer. Vaccines were selected as the gift of choice because they have contributed to the improvement of global health more than any other class of pharmac
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
2. Positive Clinical Study Results for BSPs HyperQ Technology
3. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
4. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
5. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
6. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
7. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
8. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
9. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
10. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
11. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015 Research and Markets ( ... "Argentina Biomedical Sensors Market - Growth, Trends & Forecasts ... The Argentina Biomedical Sensors market is estimated at $0.17 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
(Date:8/31/2015)... TORONTO , Aug. 31, 2015 /PRNewswire/ - Portage ... Canadian Securities Exchange: PBT.U), is pleased to announce that ... be advancing its lead candidate, PPL-003, to an Investigational ... dry eye disease and uveitis.  PPL recently completed a ... where topical PPL-003 solution achieved highly significant efficacy and ...
(Date:8/31/2015)... Israel , Aug. 31, 2015 ... Dario™ Diabetes Management Solution, today announced it recently ... million. Funds will be used to support the ... the Dario, a mobile, cloud-based, diabetes management solution ... stylish, ,all-in-one, pocket-sized, blood glucose monitoring device, and ...
(Date:8/31/2015)... ... ... Proove Biosciences, Inc. is a finalist for the Outstanding Tech Company category of ... its 22nd year, this premier awards event celebrates the best in Orange County’s technology ... world. The OC Tech Alliance will announce all winners at a gala dinner on ...
Breaking Biology Technology:Argentina Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts 2014-2020 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 2LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 3LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution 4Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 4
... March 26 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ... Leaders in the Biotech Industry conference on Thursday, April 2, ... conference is being held at the Millennium Broadway Hotel in ... Executive Officer of Anadys, will provide an overview of Anadys ...
... /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: ... on in-licensing, developing and commercializing proprietary product candidates ... today that the company,s President and CEO Theodore ... Thursday, April 2, 2009 at 9:00am Eastern Time ...
... 23, 2009 the,United States Patent and Trademark Office ... ongoing re-examination of Verathon, Inc.,s United,States Patent Number ... re-examination of this patent in 2006 following litigation ... The new Action from ...
Cached Biology Technology:Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry 2US Patent Office Rejects 95% of Verathon Claims in Patent Case With Aircraft Medical 2
(Date:8/6/2015)... , August 6, 2015 ... (SMI) shows the world,s first Eye Tracking Integration ... Moverio BT-200 see-through head mounted display and on SMI,s ... quality and efficiency is brought to personalized visualization and ... first time, professionals and researchers can integrate gaze, and ...
(Date:8/5/2015)... August 5, 2015 According to ... Management Market by Software, Services, Vertical (BFSI, Airport, IT & ... - Global Forecast to 2020", published by MarketsandMarkets, defines ... globally into various segments. The global PIAM Market is ... $546.2 Million by 2019, at a CAGR of 14.9 ...
(Date:8/5/2015)... VIEW, Calif. , Aug. 5, 2015 ... exhibits continuous growth in applications, penetration into newer sectors, ... after year. The global biosensors space has seen the ... exited the market so far. (Photo - ... Frost & Sullivan, Analysis of the Global Biosensors ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... 35,000 people and a survey across the entire human ... National Institutes of Health (NIH) has found evidence that ... play a minor role in human height. The findings ... the journal Nature Genetics. The variants most strongly ...
... Foundation (CRF) brings experts to New York City ... International Conference on Cell Therapy for Cardiovascular Diseases. ... the three-day session will feature an in-depth review ... angiogenesis and cutting-edge research findings. Highlights ...
... staple of laboratory research, may be key in ... sleep. Researchers at the University of Pennsylvania School of ... Nature that the round worm has a sleep-like state, ... physiology. This research has implications for explaining the evolution ...
Cached Biology News:Researchers uncover new piece to the puzzle of human height 2Researchers uncover new piece to the puzzle of human height 3Researchers uncover new piece to the puzzle of human height 4Cell Therapy for Cardiovascular Diseases 2Cell Therapy for Cardiovascular Diseases 3Snoozing worms help Penn researchers explain the evolution of sleep 2
... The DNA Engine instrument is ... Unprecedented thermal uniformity and ... and block-to-block. This rugged ... cycler, it's a platform for new ...
... The Multiple Species Tissue Array (MSTA) slides ... different cells and tissues from multiple species. ... on each MSTA slide which can then be ... staining, immunohistochemistry, or in situ hybridization. ...
... yellow solution. In PBS ... and other proprietary stabilizers; ... formulated to stabilize activity ... conjugates at high conjugate ...
... WinMelt software is used to ... any DNA sequence up to ... optimizing placement of primers and ... by denaturing gradient gel electrophoresis ...
Biology Products: